XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 104 filers reported holding XENON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,040,952 | +1357.4% | 1,084,337 | +1542.5% | 0.02% | +1500.0% |
| Q2 2023 | $2,541,616 | -34.2% | 66,016 | -38.9% | 0.00% | -50.0% |
| Q1 2023 | $3,863,960 | +72.4% | 107,962 | +90.0% | 0.00% | +100.0% |
| Q4 2022 | $2,241,004 | -56.5% | 56,835 | -60.2% | 0.00% | -50.0% |
| Q3 2022 | $5,152,000 | -60.6% | 142,726 | -66.8% | 0.00% | -66.7% |
| Q2 2022 | $13,079,000 | +13.6% | 429,960 | +14.2% | 0.01% | +50.0% |
| Q1 2022 | $11,514,000 | +25.3% | 376,651 | +28.1% | 0.00% | +33.3% |
| Q4 2021 | $9,188,000 | +128.6% | 294,098 | +11.8% | 0.00% | +50.0% |
| Q3 2021 | $4,020,000 | +983.6% | 263,103 | +1221.6% | 0.00% | – |
| Q2 2021 | $371,000 | – | 19,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |